Skip to main content

Want a detailed portfolio tracker?

TuHURA Biosciences (HURA) P/E (2021 - 2026)

TuHURA Biosciences (HURA) P/E from Mar 31, 2021 to Jun 3, 2026. The TTM TuHURA Biosciences (HURA) P/E is -3.77. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of TuHURA Biosciences (HURA)

YearP/EChange
2026-3.77+197.06%
2025-1.27-55.58%
2024-2.86+710.91%
2023-0.35-97.95%
2022-17.21-72.98%
2021-63.71N/A

Comparison TuHURA Biosciences (HURA) P/E with competitors

TuHURA Biosciences (HURA) P/E is -3.77.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.10-102.71%
ENLVEnlivex Therapeutics Ltd0.15-103.98%
FGENFibroGen Inc0.24-106.36%
TRAWTraws Pharma Inc0.47-112.53%
FBIOFortress Biotech Inc0.71-118.71%
CHRSCoherus Biosciences Inc0.98-125.92%
ORMPOramed Pharmaceuticals Inc1.47-139.04%
AGENAgenus Inc2.05-154.28%
VIVSVivoSim Labs Inc2.54-167.19%
INVAInnoviva Inc3.19-184.49%
CRMDCorMedix Inc3.65-196.60%
ABEOAbeona Therapeutics Inc4.20-211.42%
VXRTVaxart Inc4.26-212.92%
CVACCureVac N.V.4.45-217.80%
SRPTSarepta Therapeutics Inc4.62-222.53%
GLPGGalapagos NV4.86-228.75%
RIGLRigel Pharmaceuticals4.92-230.36%
ZVRAZevra Therapeutics Inc4.97-231.80%
ABUSArbutus Biopharma Corp5.69-250.87%
CGENCompugen Ltd7.38-295.66%
AUPHAurinia Pharmaceuticals Inc9.25-345.15%
ACADAcadia Pharmaceuticals Inc9.59-354.07%
OMEROmeros Corporation9.88-361.89%
PLXProtalix BioTherapeutics Inc9.91-362.58%
SPROSpero Therapeutics Inc10.73-384.45%
ADMAAdma Biologics Inc11.33-400.24%
SVASinovac Biotech Ltd11.44-403.04%
TBPHTheravance Biopharma Inc11.78-412.06%
HRMYHarmony Biosciences Holdings Inc12.18-422.76%
TGTXTG Therapeutics Inc13.18-449.23%
INCYIncyte Corp13.38-454.60%
SABSSAB Biotherapeutics Inc14.06-472.51%
XOMAXOMA Corp14.95-496.03%
REGNRegeneron Pharmaceuticals Inc14.98-496.95%
PBYIPuma Biotechnology Inc15.05-498.81%
EXELExelixis Inc15.79-518.54%
NAGENiagen Bioscience Inc16.35-533.38%
CPRXCatalyst Pharmaceuticals Inc17.34-559.61%
MDXGMimedx Group Inc17.38-560.42%
ARGXArgen X SE23.07-711.36%
HALOHalozyme Therapeutics Inc23.20-714.78%
XOMAOXOMA Corp25.34-771.60%
VRTXVertex Pharmaceuticals Inc25.66-779.84%
XOMAPXOMA Corp25.67-780.22%
CTMXCytomX Therapeutics Inc25.70-780.96%
ASNDAscendis Pharma A/S26.35-798.34%
RPRXRoyalty Pharma plc - Class A27.50-828.59%
SLNOSoleno Therapeutics Inc29.02-868.86%
LGNDLigand Pharmaceuticals Inc - Class B30.19-899.90%
BMRNBiomarin Pharmaceutical Inc37.51-1093.89%
APLSApellis Pharmaceuticals Inc39.02-1134.00%
KRYSKrystal Biotech Inc39.70-1151.93%
GMABGenmab40.20-1165.34%
ONCBeiGene Ltd67.03-1876.12%
TECHBio-Techne Corp68.59-1917.67%
VCELVericel Corp80.63-2236.56%
PHARPharming Group N.V.87.74-2424.99%
ALNYAlnylam Pharmaceuticals Inc124.93-3410.56%
TLXTelix Pharmaceuticals Ltd139.89-3806.90%
CORTCorcept Therapeutics Inc158.39-4297.09%